|
|||||||||||||||
| Letter of
Transmittal
Australia's Anti-Doping Framework |
Australian Sports Drug Medical Advisory Committee (ASDMAC)ResponsibilitiesASDMAC provides Australian athletes and sporting organisations with:
ASDMAC’s functions, as prescribed in the ASDA Act, appear at Appendix N. ASDMAC provides approval for therapeutic use of banned substances to athletes where:
ASDMAC MembersChairpersonProf. Ken Fitch, AM – MBBS, MD, FRACGP, FACRM, FACSM, FASMF, FACSPSports Physician, Mount Hospital Medical Centre; Adjunct Professor, Department of Human Movement, University of Western Australia; Secretary, Medication Advisory Committee, IOC Medical Commission; Deputy Chair, WADA Health, Medical and Research Committee; Member, WADA Therapeutic Use Exemption Committee; Emeritus Physician, Sports and Soft Tissue Injury Clinic, Department of Orthopaedic Surgery, Royal Perth Hospital. MembersProf. Peter Fricker, OAM – MBBS, FACSM, FASMF, FACSPDirector of Medical Service, AIS; Head of Sports Sciences and Sports Medicine, AIS; Adjunct Professor of Sports Faculty of Science and Design, University of Canberra; Chair Medical Commission, Australian Commonwealth Games Association; Member, Medical Commission, AOC. Dr. Susan White, MBBS (Hons), FACSPMember, Medical Commission Australian Paralympic Committee; Chief Medical Officer, Netball Australia; Team Doctor, Australian Netball Team; Medical Officer, Victorian Football League Umpires; Victorian Training Coordinator, Australian College of Sports Physicians; Medical Officer, Victorian Institute of Sport (Rowing); Sports Physician, Olympic Park Sports Medicine Centre (Melbourne). Dr. Peter Harcourt, MBBS, FACSP Dip ObsSports Physician; Medical Coordinator, Victorian Institute of Sport, AIS Medical Convenor, Transport Accident Commission (Victoria); Chief Medical Officer, Basketball Australia; Medical Officer, Australian Football League; Anti-Doping Medical Officer, Australian Cricket Board; Member, International Basketball Federation Medical Council; Member, Medical Commission, Australian Commonwealth Games Association. Dr. Hugh Hazard, MBBS, Grad Dip Sports Science, FACSPSports Physician; Chief Medical Officer and Team Physician, National Rugby League; Team Physician, National Basketball League.
ASDMAC Members Top left Chairman Prof. Ken Fitch – AM, Prof. Peter Fricker – OAM,Front left Dr. Hugh Hazard, Dr. Susan White, Dr. Peter Harcourt Approvals ProcessThe approvals process involves examining a wide range of athlete applications. Some applications are complex and necessitate referral to an independent referee while others are relatively simple. Athletes seeking approval for therapeutic use of a banned substance should apply via their NSO’s medical officer. An athlete who applies directly to ASDMAC is advised that their NSO will be informed of the application. The application is registered on ASDMAC’s database, provided a reference number, then faxed to the ASDMAC Chairperson to ensure sufficient information is available to process the application. If ASDMAC determines the application fulfils the criteria, the Committee prepares an Approval for Therapeutic Use of a Prohibited Medication. ASDMAC can attach conditions or constraints to approvals e.g. that an approval is not recognised by the athlete’s international sports federation and if tested under their international policy an athlete could be sanctioned. An athlete must comply with any conditions or the approval may be withdrawn. If further information is required the applicant must provide the additional requested information for the application to be progressed further. If ASDMAC determines the request does not meet specific guidelines the athlete will be advised that:
Once the application’s outcome is determined, the athlete and the NSO are advised. Details of athletes who receive approval for therapeutic use are entered onto an approvals register from which ASDA may seek information for decision-making purposes. ActivitiesFor the year ending 30 June 2002 ASDMAC:
Hyperactivity Disorder via consultation with other experts;
International TrendsASDMAC’s operations were consistent with international anti-doping trends. The Olympic Movement Anti-Doping Code contains therapeutic use provisions that enabled systems (similar to ASDMAC), to operate nationally and internationally subject to transparency and accountability provisions. WADA sought ASDMAC advice in relation to the guidelines and protocols for the therapeutic use of prohibited medications by athletes. WADA adopted almost all of ASDMAC’s protocols and established a medical committee similar to ASDMAC. The ASDA Act provides accountability, transparency and independence for ASDMAC to operate within international and domestic sport frameworks. Leading sports medicine practitioners regarded ASDMAC’s framework as best practice. FundingASDMAC was funded via ASDA appropriation.
|
||||||||||||||
| |
